Mark Malkin, MD

Appointed
2022

Education & Fellowships

Fellowship - Memorial Sloan Kettering Cancer Center
Neuro-oncology
New York, NY
1988

Residency - University of Toronto Post Grad Med Ed
Neurology
Toronto, ON Canada
1984

Residency - Sunnybrook Medical Center
Internal Medicine
Toronto, ON Canada
1981

Medical Education - University of Toronto Faculty of Medicine (Canada)
Toronto, Ontario, Canada
1979

Undergraduate - University College
Premedical studies, Faculty of Arts and Sciences
Toronto/Canada, ON Canada
1975

Additional Training

• Leadership Development for Physicians in
  Academic Health Centers, T.H. Chan School
  Of Public Health, Harvard University, Boston, MA, 2015
  
  Faculty Leadership Development Program,
  University of Wisconsin-Milwaukee, WI, 2013
  
  Lean for Healthcare, School of Engineering,
  University of Michigan, Ann Arbor, MI, 2012

Professional Highlights

• 06/2022 – present Professor of Neurology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  09/2014 – 05/2022 Professor of Neurosurgery, Virginia Commonwealth University, Richmond, VA
  11/2013 – 05/2022 Member, Developmental Therapeutics Program, Massey Cancer Center, Virginia Commonwealth University
  09/2013 – 05/2022 Professor of Neurology, Virginia Commonwealth University
  02/2007 – 08/2013 Professor of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI
  07/2005 – 08/2013 Professor of Neurology, Medical College of Wisconsin
  05/2004 – 06/2005 Associate Professor of Neurology, Medical College of Wisconsin
  11/1996 – 08/2003 Associate Professor of Clinical Neurology, Cornell University Medical College, New York, NY
  04/1996 – 08/2003 Associate Clinical Member, Memorial Sloan-Kettering Cancer Center, New York, NY
  02/1988 – 10/1996 Assistant Professor of Neurology, Cornell University Medical College
  09/1990 – 03/1996 Assistant Member, Memorial Sloan-Kettering Cancer Center
  02/1988 – 08/1990 Clinical Assistant, Memorial Sloan-Kettering Cancer Center

Certifications

• Neuro-oncology

Specialty Interests

Primary brain tumors, nervous system metastases, neurologic complications of cancer therapy, quality of life

Awards & Honors

• 2020 Highest Evaluation Teaching Award, M3 Neurology Clerkship, VCU
  2019 Best Bedside Manner Award, One Health for Richmond Magazine, Honorable Mention
  2019 Highest Evaluation Teaching Award, M3 Neurology Clerkship, VCU
  2016 Highest Evaluation Teaching Award, M3 Neurology Clerkship, VCU
  2016-present Advocacy Champion, American Society of Clinical Oncology
  2016 Awarded Tenure as Professor, Department of Neurology, School of Medicine, VCU
  2015 Highest Evaluation Teaching Award, M3 Neurology Clerkship, VCU
  2013 Appointed the William G. Reynolds Jr. Chair in Neuro-oncology, VCU
  2009-2010 Outstanding Medical Student Teacher in Neurology, Medical College of Wisconsin (MCW)
  2005-present Selected continuously to “Best Doctors in America” Database
  2005 Elected to Fellowship, American Academy of Neurology
  2005 Excellence in Clinical Teaching Award, Department of Neurology, MCW
  1990-1993 Clinical Oncology Career Development Award, American Cancer Society
  1985-1986 Canadian-American Bumper-Borden Foundation Fellow, Memorial Sloan-Kettering Cancer Center
  1975 University College Alumni Scholarship, University of Toronto
  1973 Ontario Scholarship, Government of Ontario

Memberships

• 2018-2022 Neurology Delegate, Medical Society of Virginia
  2016-2022 Member, Legislative Committee, Richmond Academy of Medicine
  2014-2022 Member, Richmond Academy of Medicine
  2014-2022 Member, Virginia Neurological Society
  2005-2013 Vice-Chair, Neuro-oncology Examination Committee, United Council for Neurologic Subspecialties
  2004-2013 Member, Wisconsin Neurological Society
     President-Elect, 2012-2013
     Secretary/Treasurer, 2007-2001
  2004-2013 Member, Central Society for Neurological Research
     President, 2011-2013
     Secretary/Treasurer, 2006-2011
  2004-2008 Medical College of Wisconsin Representative, Wisconsin Cancer Council
  1996-present Member, The Canadian Neurological Society
  1994-present Founding Member, The Society for Neuro-oncology
  1988-present Active Member, The American Society of Clinical Oncology
  1982-present Member, The American Academy of Neurology
     Chair, Section of Neuro-oncology, 2006-2008
     Chair-Elect, Section of Neuro-oncology, 2004-2006
   Member, Long-Range Planning Work Group, Section of Neuro-oncology, 2003-2004
     Fellowship Director, Section of Neuro-oncology, 2002-2006
     Chair, Nominating Committee, Section of Neuro-oncology, 1997-1998

See publications for Mark Malkin, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/22/2024, Dr. Malkin has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.